Search alternatives:
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
105021
-
105022
-
105023
-
105024
Table1_Molecular subtyping of acute myeloid leukemia through ferroptosis signatures predicts prognosis and deciphers the immune microenvironment.XLS
Published 2023“…<p>Acute myeloid leukemia (AML) is one of the most aggressive hematological malignancies with a low 5-year survival rate and high rate of relapse. …”
-
105025
Image3_Molecular subtyping of acute myeloid leukemia through ferroptosis signatures predicts prognosis and deciphers the immune microenvironment.TIF
Published 2023“…<p>Acute myeloid leukemia (AML) is one of the most aggressive hematological malignancies with a low 5-year survival rate and high rate of relapse. …”
-
105026
Image1_Molecular subtyping of acute myeloid leukemia through ferroptosis signatures predicts prognosis and deciphers the immune microenvironment.TIF
Published 2023“…<p>Acute myeloid leukemia (AML) is one of the most aggressive hematological malignancies with a low 5-year survival rate and high rate of relapse. …”
-
105027
Table2_Molecular subtyping of acute myeloid leukemia through ferroptosis signatures predicts prognosis and deciphers the immune microenvironment.XLSX
Published 2023“…<p>Acute myeloid leukemia (AML) is one of the most aggressive hematological malignancies with a low 5-year survival rate and high rate of relapse. …”
-
105028
Image2_Molecular subtyping of acute myeloid leukemia through ferroptosis signatures predicts prognosis and deciphers the immune microenvironment.TIF
Published 2023“…<p>Acute myeloid leukemia (AML) is one of the most aggressive hematological malignancies with a low 5-year survival rate and high rate of relapse. …”
-
105029
-
105030
<i>Dnmt3L</i> haploinsufficiency resulted in altered expression of the <i>Dnmt3L</i> splice variants.
Published 2011“…Black bars = wildtype, white bars = heterozygous, n = 3 biological replicates (10 mice/replicate). Results are presented as means ± SEM. …”
-
105031
Muscle strength and quality of life in patients with childhood cancer at early phase of primary treatment
Published 2016“…Forty children and adolescents aged 5–18 years (mean: 11.39 ± 4.08 years) with different types of childhood cancer were enrolled. …”
-
105032
-
105033
-
105034
The Non-Classical MAP Kinase ERK3 Controls T Cell Activation
Published 2014“…Moreover, ERK3 protein is phosphorylated and associates with MK5 in activated primary T cells. We show that ERK3-deficient T cells have a decreased proliferation rate and are impaired in cytokine secretion following <i>in vitro</i> stimulation with low dose of anti-CD3 antibodies. …”
-
105035
-
105036
-
105037
-
105038
-
105039
-
105040